PCM Encore »

Takeda Pharmaceutical shares owned by PCM Encore

Quarter-by-quarter ownership of Takeda Pharmaceutical (TAK) shares owned by PCM Encore from 13F filings

Historical chart of PCM Encore investment in Takeda Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Takeda Pharmaceutical held by PCM Encore consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Takeda Pharmaceutical by PCM Encore

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.4M 77k 18.52

More positions owned by PCM Encore

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Amazon (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Russell 2000 Etf (IWM)
Broadcom (AVGO)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
Exxon Mobil Corporation (XOM)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for PCM Encore

Top funds holding Takeda Pharmaceutical

Capital Research Global Investors
Arrowstreet Capital, Limited Partnership
Goldman Sachs Group
D. E. Shaw & Co
FMR
Brandes Investment Partners
BlackRock
UBS Group
Renaissance Technologies
Van Eck Associates Corp.
First Trust Advisors
Citadel Advisors
Managed Asset Portfolios
Northern Trust
Envestnet Asset Management

View all funds holding Takeda Pharmaceutical